RIO DE JANEIRO, BRAZIL - The Cuban drug "Recombinant Interferon alfa 2b (IFNrec)" is one of 30 drugs selected to fight the coronavirus Covid-19 in China. According to media reports, it has already cured more than 1,500 patients. Since January 25th, it has been produced in the Chinese-Cuban plant Chanheber in the province of Jilin, according to the Cuban embassy in China.
According to specialists, it has so far been used to treat viral infections such as HIV/AIDS, recurrent respiratory papillomatosis, a respiratory tumor, and hepatitis B and C.
Developed in 1986 by Cuban researchers at the . . .